Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 23.29 M19.43 M20 M22.94 M28.64 M31.34 M 102.91 M Research & development —————— — Operating income 9.96 M20.1 M21.81 M21.06 M21.45 M34.83 M 99.16 M Non-Operating Income, Total -80 K380 K51 K3.8 M-174 K280 K 3.95 M Interest expense, net of interest capitalized 11.37 M11.89 M10 M11.3 M12.65 M15.28 M 49.23 M Non-Operating Income, excl. Interest Expenses -11.37 M-11.89 M-10 M-11.3 M-12.65 M-15.28 M -49.23 M Unusual income/expense -80 K380 K51 K3.8 M-174 K-280 K 3.39 M Pretax income -1.49 M8.59 M11.86 M13.56 M8.63 M19.27 M 53.32 M Equity in earnings —————— — Taxes 3.31 M1.78 M4.22 M5.85 M838 K5.23 M 16.14 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -4.8 M6.81 M7.64 M7.71 M7.79 M14.03 M 37.18 M Discontinued operations —————— — Net income -4.8 M6.81 M7.64 M7.71 M7.79 M14.03 M 37.18 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -4.8 M6.81 M7.64 M7.71 M7.79 M14.03 M 37.18 M Basic earnings per share (Basic EPS) -0.040.050.060.060.060.11 0.29 Diluted earnings per share (Diluted EPS) -0.040.050.060.060.060.11 0.29 Average basic shares outstanding 132.18 M132.32 M132.32 M132.32 M132.53 M132.53 M — Diluted shares outstanding 132.18 M132.32 M132.32 M132.32 M132.53 M132.53 M — EBITDA 20.02 M24.44 M26.95 M49.82 M27.11 M60.74 M 164.62 M EBIT 9.96 M20.1 M21.81 M21.06 M21.45 M34.83 M 99.16 M Cost of revenue 60.67 M68.08 M71.85 M80.88 M87.34 M103.83 M 343.9 M Other cost of goods sold 58 M65.26 M69.01 M77.9 M84.49 M— — Depreciation & amortization (cash flow) 10.06 M4.33 M5.14 M28.75 M5.66 M25.91 M 65.47 M